The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
TOKYO - PTC Therapeutics, Inc. (NASDAQ:PTCT) announced Monday that its drug Sephience (sepiapterin) has received approval from the Japanese Ministry of Health, Labor and Welfare for treating ...
WARREN, N.J., Dec. 22, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT ) announced today that SephienceTM (sepiapterin) has been approved by the Japanese Ministry of Health, Labor and ...
Earlier in December, PTC Therapeutics announced that Japan’s Ministry of Health, Labor and Welfare approved Sephience (sepiapterin) for treating children and adults with phenylketonuria, marking the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results